{"id":"W4213017736","doi":"10.1097/01.cot.0000821988.50798.78","title":"Durvalumab + Tremelimumab Improves Survival in Advanced Liver Cancer","year":2022,"lang":"en","type":"article","venue":"Oncology Times","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tremelimumab; Durvalumab; Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Oncology; Cancer; Liver cancer; Immunotherapy; Gastroenterology; Nivolumab; Ipilimumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002487572,0.0001475098,0.0003984047,0.0001441058,0.0001212827,0.000004568141,0.00009243895,0.00008013336,0.005320066],"category_scores_gemma":[0.00002703181,0.0001365463,0.0001091157,0.0002434488,0.00005715641,0.00005155475,0.000105768,0.0002788673,0.00006374746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006154272,"about_ca_system_score_gemma":0.0004146578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000480558,"about_ca_topic_score_gemma":0.0002980221,"domain_scores_codex":[0.9987663,0.0001994038,0.0002181718,0.0003077706,0.0001997745,0.0003085594],"domain_scores_gemma":[0.9995061,0.0001146763,0.00006955472,0.0001914523,0.00003381479,0.00008439205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001358092,0.0010924,0.7400363,0.00004225518,0.0001675457,0.001664596,0.001084253,0.00001500272,0.007579454,0.0002014816,0.004215721,0.2425429],"study_design_scores_gemma":[0.01869775,0.006592366,0.3781178,0.00004449534,0.0005202762,0.0001927179,0.001743813,0.005538131,0.00543726,0.000211739,0.5823265,0.000577174],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9604461,0.004791881,0.000001675038,0.00245469,0.0004013549,0.0005378513,0.00001958527,0.00006304178,0.03128389],"genre_scores_gemma":[0.9821668,0.0003385031,0.000364715,0.000455428,0.00009246155,0.0006280342,0.0000562651,0.00002560434,0.01587217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5781108,"threshold_uncertainty_score":0.9955892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04887956912497531,"score_gpt":0.2980527105966843,"score_spread":0.249173141471709,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}